cytarabine
- Product NDC
- 25021-223
- 11-digit product format
- 250210223
- Labeler code
- 25021
- Product ID
- 25021-223_90be6aab-dfa3-4d2f-9dcb-cc1858f7c67e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cytarabine
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA211938
- Marketing category
- ANDA
- Marketing start
- 2023-06-01
- Substance
- CYTARABINE
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 04079A1RDZ | CYTARABINE | 147-94-4 | CYTARABINE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 25021-223-20 | 25021022320 | 1 VIAL in 1 CARTON (25021-223-20) / 20 mL in 1 VIAL | 1 vial | 2023-06-01 | No | No | Historical |